XIGA 10 MG

Xiga 10 mg Tablets, ideal for online pharmacies, product catalogs, and health platforms:

Xiga 10 mg Tablets (14s) – Dapagliflozin for Type 2 Diabetes & Heart‑Kidney Protection

Overview:
Xiga contains Dapagliflozin 10 mg, a sodium‑glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar in adults with type 2 diabetes mellitus. Manufactured by CCL Pharmaceuticals in Pakistan, it promotes removal of excess glucose via urine, supporting both glycemic control and weight management 

Key Benefits & Uses

• Reduces fasting and post-meal blood glucose levels

• Can assist in weight loss and reduce risk of hospitalization for heart failure in diabetic patients

• May help preserve kidney function in chronic kidney disease i

• osage & Administration

• Standard dose: 10 mg once daily, taken at the same time each day, with or without food Tablets should be swallowed whole; do not crush, chew, or break 

Safety & Side Effects

• Common side effects:

  • Increased urination, dehydration, thirst

  • Urinary tract infections or genital yeast infections

  • Dizziness or low blood pressure (especially in older adults or those on diuretics)\Rare but serious: diabetic ketoacidosis, risk of Fournier’s gangrene, kidney injury in susceptible individuals \

🩺 Important Precautions

• Use cautiously in renal impairment. Not recommended if eGFR is below 45 mL/min/1.73 m², and should be avoided if below 30 mL/min/1.73 m² \

• Ensure adequate hydration to avoid volume depletion

• May cause hypoglycemia when combined with insulin or sulfonylureas; dosage adjustment may be needed